NCT06070870

Brief Summary

Evaluate the impact of the patient navigation program on the proportion of patients who complete lung cancer screening (LCS), defined as undergoing a low dose computed tomography (LDCT)

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
675

participants targeted

Target at P75+ for not_applicable lung-cancer

Timeline
11mo left

Started Oct 2023

Typical duration for not_applicable lung-cancer

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress74%
Oct 2023Apr 2027

First Submitted

Initial submission to the registry

September 30, 2023

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 6, 2023

Completed
4 days until next milestone

Study Start

First participant enrolled

October 10, 2023

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2027

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2027

Last Updated

March 16, 2026

Status Verified

March 1, 2026

Enrollment Period

3.5 years

First QC Date

September 30, 2023

Last Update Submit

March 12, 2026

Conditions

Keywords

Lung cancerScreening

Outcome Measures

Primary Outcomes (1)

  • Number of study patients who complete lung cancer screening (LCS) through the patient navigation process

    Evaluate the impact of the patient navigation program on the number of patients who complete lung cancer screening (LCS), defined as undergoing a low dose computed tomography (LDCT).

    2 weeks to 4 months following day 1, varies by participant

Secondary Outcomes (6)

  • Assess the feasibility and acceptability of the patient navigation program

    Day 1

  • Assess the feasibility and acceptability of the patient navigation program

    2 weeks to 4 months following day 1, varies by participant

  • Assess the impact of the patient navigation program on patient health-related quality of life at baseline.

    Day 1

  • Assess the impact of the patient navigation program on patient health-related quality of life after navigation intervention.

    2 weeks to 4 months following day 1, varies by participant

  • Assess the impact of the patient navigation program on patient financial distress

    Day 1

  • +1 more secondary outcomes

Study Arms (1)

Patient Navigation

EXPERIMENTAL

Centralized patient navigators will be trained to help patients navigate the clinical, logistical, and financial aspects of LCS. Navigators employ case management approaches based on social work principles. The experience of patient navigation will be tailored to the individual participant

Behavioral: Patient Navigation

Interventions

Navigation will address the following 4 domains of barriers to screening: * Individual * Organizational * Economic * Sociocultural At the first visit, navigators will assess the participant's barriers in each of these domains. Any follow-up visits, if necessary, will be used to help the participant overcome these barriers to screening

Patient Navigation

Eligibility Criteria

Age50 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Meets current USPSTF guidelines for lung cancer screening (LCS)
  • pack-year smoking history Note: A pack-year is a way of calculating how much a person has smoked in their lifetime.
  • One pack-year is the equivalent of smoking an average of 20 cigarettes-1 pack-per day for a year.
  • Currently smokes or has quit smoking within the past 15 years
  • Identifies as Black or African-American Note: Both Hispanic/Latino and Non-Hispanic/Latino patients are eligible as long as they also identify as Black or African-American (eg, Afro-Latino).
  • Willing to complete all navigation-related study activities
  • Able to understand and the willingness to sign a written informed consent document

You may not qualify if:

  • Known history of cancer (except squamous cell skin cancer), or coughing up blood in the past 5 years, as reported by the individual
  • Has undergone a previous lung cancer screening
  • Inability to speak English
  • Medical, psychological, or social condition that, in the opinion of the investigator, may increase the patient's risk or limit the patient's adherence with study requirements

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

University of North Carolina-Chapel Hill

Carrboro, North Carolina, 27510, United States

RECRUITING

Medical University of South Carolina

Charleston, South Carolina, 29425, United States

RECRUITING

Virginia Commonwealth University

Richmond, Virginia, 23298, United States

RECRUITING

MeSH Terms

Conditions

Lung Neoplasms

Interventions

Patient Navigation

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Patient-Centered CarePrimary Health CareComprehensive Health CarePatient Care ManagementHealth Services Administration

Study Officials

  • Vanessa Sheppard, PhD

    Virginia Commonwealth University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Massey IIT Research Operations

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 30, 2023

First Posted

October 6, 2023

Study Start

October 10, 2023

Primary Completion (Estimated)

March 31, 2027

Study Completion (Estimated)

April 30, 2027

Last Updated

March 16, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Currently there is not a plan to share with other researchers not working on the protocol.

Locations